JP Morgan Downgrades Johnson & Johnson to "Neutral" on Valuation Call (JNJ)

JP Morgan Downgrades Johnson & Johnson to “Neutral” on Valuation Call (JNJ)


JP Morgan analysts downgraded health care products maker Johnson & Johnson (JNJ) on Monday on a valuation call.

The analysts downgraded JNJ from “Overweight” to “Neutral” and see shares reaching $83. This target suggests a 1% upside to Friday’s closing price of $82.04.

Johnson & Johnson shares were down 50 cents, or -0.61%, during pre-market trading on Monday. The stock is up +17.03% year-to-date.

The Bottom Line
Shares of Johnson & Johnson (JNJ) have a dividend yield of 2.97% based on Friday’s closing price of $82.04 and the company’s annualized dividend payout of $2.44 per share.

Johnson & Johnson (JNJ) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today